Vairapandi M, Balliet A G, Fornace A J, Hoffman B, Liebermann D A
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Oncogene. 1996 Jun 20;12(12):2579-94.
Towards dissecting the regulation of terminal differentiation, including growth arrest and apoptosis, myeloid differentiation primary response (MyD) genes, induced in the absence of de novo protein synthesis following induction of M1 myeloblastic leukemia cells for terminal differentiation have been isolated. MyD118 was one of the novel MyD genes cloned, subsequently observed also to be a primary response gene to TGF-beta, which induces M1 cells for growth arrest and apoptosis uncoupled from differentiation. The MyD118 encoded protein was observed to be remarkably similar to the protein encoded by Gadd45, a growth arrest and DNA damage induced gene, regulated in part by the tumor suppressor p53. Though evidence has accumulated that MyD118 functions as an important modulator of negative growth control both in hematopoietic and non-hematopoietic cells, its mechanism of action is unknown. To better understand the role(s) of MyD118 in negative growth control, we have analysed the expression and biological characteristics of the MyD118 protein, compared to the Gadd45 protein, in distinct pathways of growth arrest and apoptosis, including p53 dependent and independent pathways either coupled or uncoupled from differentiation. It is shown that MyD118 and Gadd45 differentially accumulated upon induction of distinct pathways of growth arrest and apoptosis; notably, MyD118, but not Gadd45, was induced by TGF-beta, whereas Gadd45, but not MyD118, was induced by activating wild type (wt) p53 function. It is also shown that MyD118 is a nuclear protein, which regardless of the pathway induced, predominantly localized within the cell nucleus, and interacted with the DNA replication and repair protein PCNA and the cyclin dependent kinase inhibitor P21WAF1/CIP1. MyD118 also modestly stimulated DNA repair in vitro. All of these characteristics were shared with Gadd45. Finally, it is demonstrated that MyD118, Gadd45 and p21 synergized in the suppression of colony formation by NIH3T3 cells. Taken together, these findings demonstrate that MyD118 and Gadd45 are representative of a new protein family that share remarkable functional similarities in the control of distinct pathways of negative growth, including the suppression of cellular growth and programmed cell death.
为了剖析终末分化的调控机制,包括生长停滞和凋亡,在诱导M1髓母细胞白血病细胞进行终末分化后,在无从头蛋白质合成的情况下诱导产生的髓系分化初级反应(MyD)基因已被分离出来。MyD118是克隆出的新型MyD基因之一,随后还观察到它是对转化生长因子-β(TGF-β)的初级反应基因,TGF-β可诱导M1细胞生长停滞和凋亡,且与分化无关。观察到MyD118编码的蛋白质与Gadd45编码的蛋白质非常相似,Gadd45是一种生长停滞和DNA损伤诱导基因,部分受肿瘤抑制因子p53调控。尽管已有证据表明MyD118在造血细胞和非造血细胞中均作为负生长控制的重要调节因子发挥作用,但其作用机制尚不清楚。为了更好地理解MyD118在负生长控制中的作用,我们分析了MyD118蛋白与Gadd45蛋白在生长停滞和凋亡的不同途径中的表达及生物学特性,这些途径包括与分化相关或不相关的p53依赖性和非依赖性途径。结果表明,在诱导不同的生长停滞和凋亡途径时,MyD118和Gadd45的积累情况不同;值得注意的是,TGF-β可诱导MyD118而非Gadd45,而激活野生型(wt)p53功能可诱导Gadd45而非MyD118。还表明MyD118是一种核蛋白,无论诱导何种途径,它主要定位于细胞核内,并与DNA复制和修复蛋白增殖细胞核抗原(PCNA)以及细胞周期蛋白依赖性激酶抑制剂P21WAF1/CIP1相互作用。MyD118在体外也适度刺激DNA修复。所有这些特性Gadd45也具备。最后,证明了MyD118、Gadd45和p21在抑制NIH3T3细胞集落形成方面具有协同作用。综上所述,这些发现表明MyD118和Gadd45代表了一个新的蛋白质家族,它们在控制不同的负生长途径,包括抑制细胞生长和程序性细胞死亡方面具有显著的功能相似性。